by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,
by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,
byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic
byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic
by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re
by Sylvester Comprehensive Cancer CenterSylvester researcher Sophia George, Ph.D., who was raised in the Caribbean country of Dominica. Credit: Sylvester Comprehensive Cancer CenterA new study from re
by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer
by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer
by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco
by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco
by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how
by Monash UniversityDr. Richard Berry with lab members Dr. Gabby Watson, Zhihui Fu and Felix Deuss. Credit: Monash UniversityNew research undertaken at Monash University has shed new light on how
by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
by Olivia Dimmer,Northwestern UniversityNorthwestern Medicine scientists in the Sonabend laboratory have identified an enzyme which aids tumors in evading the immune system. Credit: Northwestern
byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
by University of DundeeCredit: University of DundeeA new method offering more successful diagnosis and management of prostate cancer has been identified by researchers at the University of Dundee
by University of DundeeCredit: University of DundeeA new method offering more successful diagnosis and management of prostate cancer has been identified by researchers at the University of Dundee
by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t
by British Medical JournalCredit: CC0 Public DomainLarge differences in radiation doses used for CT scans are mainly due to how the scanners are used by medical staff rather than differences in t
byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m
byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m